InvestorsHub Logo
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

Re: Jesspro post# 61867

Friday, 04/17/2015 12:52:50 PM

Friday, April 17, 2015 12:52:50 PM

Post# of 80490
Let me refresh your memory. Back in 2013, Adam Feuerstein wrote his now infamous article claiming a short seller friend of his told him there were toxicity issues with Ponatinib. Most Ariad investors called him a "shill for the shorts".

Harvey Berger, on the other hand, swore on a stack of bibles that there were no such toxicity issues. He vowed that the only thing that they were seeing that Ponatinib was "well tolerated" (even though we now know that all the while the FDA was in constant contact with Ariad about Ponatinib's problems). He even held his now infamous "if I could buy more I would" press conference to refute Adam's Flavus column.

Remarkably, even though Adam Feuerstein turned out to be 100% correct and Harvey Berger was completely lying through his teeth, some here still call Feuestein a shill while they pray that Berger keeps control of Ariad.

That's truly unbelievable.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.